Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SAGE Therapeutics

Request full access

Develops and delivers novel medicines for most debilitating and disabling central nervous system disorders

Raleigh, United StatesFounded 2010Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2014

SAGE Therapeutics in the Raleigh ecosystem

Live from Dealroom

The SAGE Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later5 investors entered at this stage

Employees mapped 193 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 31 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$273M

124 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See SAGE Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.